TargetMol

W10294A

Product Code:
 
TAR-T35097
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T35097-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
W10294A is a biochemical.
CAS:
41806-51-3
Formula:
C21H30Cl2N2O4
Molecular Weight:
445.38
Purity:
0.98
SMILES:
Cl.Cl.COc1cc2oc(=O)c3CN(CCN4CCCCC4)CCc3c2cc1OC

References

Littner MR. W10294A: a new bronchodilator. Lung. 1977;154(3):187-94. PubMed PMID: 916727. Van Berkum JJ, Koornneef AW, Otten M, Nieuwland MS. Establishing reference in language comprehension: an electrophysiological perspective. Brain Res. 2007 May 18;1146:158-71. Epub 2006 Aug 17. PubMed PMID: 16916496. Littner MR, Schachter EN, Bouhuys A. Modification of induced airway constriction in healthy subjects. Ann Allergy. 1979 Sep;43(3):135-43. PubMed PMID: 475062. Tr?ger A, Siepermann M, Mahotka C, Wethkamp N, B?lle H, Laws HJ, Escherich G, Janka-Schaub G, G?bel U, Dilloo D. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Klin Padiatr. 2007 May-Jun;219(3):127-33. PubMed PMID: 17525905.